Literature DB >> 12621583

Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller-Dieker syndrome, and other phenotypes secondary to deletions of 17p13.3.

Carlos Cardoso1, Richard J Leventer, Heather L Ward, Kazuhito Toyo-Oka, June Chung, Alyssa Gross, Christa L Martin, Judith Allanson, Daniela T Pilz, Ann H Olney, Osvaldo M Mutchinick, Shinji Hirotsune, Anthony Wynshaw-Boris, William B Dobyns, David H Ledbetter.   

Abstract

Deletions of 17p13.3, including the LIS1 gene, result in the brain malformation lissencephaly, which is characterized by reduced gyration and cortical thickening; however, the phenotype can vary from isolated lissencephaly sequence (ILS) to Miller-Dieker syndrome (MDS). At the clinical level, these two phenotypes can be differentiated by the presence of significant dysmorphic facial features and a more severe grade of lissencephaly in MDS. Previous work has suggested that children with MDS have a larger deletion than those with ILS, but the precise boundaries of the MDS critical region and causative genes other than LIS1 have never been fully determined. We have completed a physical and transcriptional map of the 17p13.3 region from LIS1 to the telomere. Using fluorescence in situ hybridization, we have mapped the deletion size in 19 children with ILS, 11 children with MDS, and 4 children with 17p13.3 deletions not involving LIS1. We show that the critical region that differentiates ILS from MDS at the molecular level can be reduced to 400 kb. Using somatic cell hybrids from selected patients, we have identified eight genes that are consistently deleted in patients classified as having MDS. In addition, deletion of the genes CRK and 14-3-3 epsilon delineates patients with the most severe lissencephaly grade. On the basis of recent functional data and the creation of a mouse model suggesting a role for 14-3-3 epsilon in cortical development, we suggest that deletion of one or both of these genes in combination with deletion of LIS1 may contribute to the more severe form of lissencephaly seen only in patients with MDS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12621583      PMCID: PMC1180354          DOI: 10.1086/374320

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  35 in total

1.  Expression map of human chromosome region 17p13.3, spanning the RP13 dominant retinitis pigmentosa locus, the Miller-Dieker lissencephaly syndrome (MDLS) region, and a putative tumour suppressor locus.

Authors:  J C McHale; A B McKie; E E Tarttelin; C F Inglehearn
Journal:  Cytogenet Cell Genet       Date:  2000

2.  The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression.

Authors:  Y J Kim; S Noguchi; Y K Hayashi; T Tsukahara; T Shimizu; K Arahata
Journal:  Hum Mol Genet       Date:  2001-05-15       Impact factor: 6.150

3.  The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors.

Authors:  I Jordens; M Fernandez-Borja; M Marsman; S Dusseljee; L Janssen; J Calafat; H Janssen; R Wubbolts; J Neefjes
Journal:  Curr Biol       Date:  2001-10-30       Impact factor: 10.834

4.  Large genomic duplicons map to sites of instability in the Prader-Willi/Angelman syndrome chromosome region (15q11-q13).

Authors:  S L Christian; J A Fantes; S K Mewborn; B Huang; D H Ledbetter
Journal:  Hum Mol Genet       Date:  1999-06       Impact factor: 6.150

5.  LIS1 missense mutations cause milder lissencephaly phenotypes including a child with normal IQ.

Authors:  R J Leventer; C Cardoso; D H Ledbetter; W B Dobyns
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

6.  The location and type of mutation predict malformation severity in isolated lissencephaly caused by abnormalities within the LIS1 gene.

Authors:  C Cardoso; R J Leventer; N Matsumoto; J A Kuc; M B Ramocki; S K Mewborn; L L Dudlicek; L F May; P L Mills; S Das; D T Pilz; W B Dobyns; D H Ledbetter
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

7.  A chemical-genetic strategy implicates myosin-1c in adaptation by hair cells.

Authors:  Jeffrey R Holt; Susan K H Gillespie; D William Provance; Kavita Shah; Kevan M Shokat; David P Corey; John A Mercer; Peter G Gillespie
Journal:  Cell       Date:  2002-02-08       Impact factor: 41.582

8.  Physical and transcriptional mapping of the 17p13.3 region that is frequently deleted in human cancer.

Authors:  C Hoff; P Seranski; J Mollenhauer; B Korn; T Detzel; R Reinhardt; J Ramser; A Poustka
Journal:  Genomics       Date:  2000-11-15       Impact factor: 5.736

9.  A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system.

Authors:  S Sasaki; A Shionoya; M Ishida; M J Gambello; J Yingling; A Wynshaw-Boris; S Hirotsune
Journal:  Neuron       Date:  2000-12       Impact factor: 17.173

10.  Fluorescence in situ hybridization analysis with LIS1 specific probes reveals a high deletion mutation rate in isolated lissencephaly sequence.

Authors:  D T Pilz; M E Macha; K S Precht; A C Smith; W B Dobyns; D H Ledbetter
Journal:  Genet Med       Date:  1998 Nov-Dec       Impact factor: 8.822

View more
  59 in total

Review 1.  Miller-Dieker syndrome: analysis of a human contiguous gene syndrome in the mouse.

Authors:  Jessica Yingling; Kazuhito Toyo-Oka; Anthony Wynshaw-Boris
Journal:  Am J Hum Genet       Date:  2003-08-05       Impact factor: 11.025

Review 2.  Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes.

Authors:  Carol Mackintosh
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

3.  A new case of duplication of the MDS region identified by high-density SNP arrays and a review of the literature.

Authors:  Flavio Faletra; Raffaella Devescovi; Vanna Pecile; Antonella Fabretto; Marco Carrozzi; Paolo Gasparini
Journal:  J Appl Genet       Date:  2010-11-03       Impact factor: 3.240

4.  Role of the actin-binding protein profilin1 in radial migration and glial cell adhesion of granule neurons in the cerebellum.

Authors:  Marco B Rust; Jan A Kullmann; Walter Witke
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

5.  Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations.

Authors:  C Toma; B Torrico; A Hervás; R Valdés-Mas; A Tristán-Noguero; V Padillo; M Maristany; M Salgado; C Arenas; X S Puente; M Bayés; B Cormand
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

6.  Evidence for involvement of TRE-2 (USP6) oncogene, low-copy repeat and acrocentric heterochromatin in two families with chromosomal translocations.

Authors:  Zhishuo Ou; Małgorzata Jarmuz; Steven P Sparagana; Jacques Michaud; Jean-Claude Décarie; Svetlana A Yatsenko; Beata Nowakowska; Patti Furman; Chad A Shaw; Lisa G Shaffer; James R Lupski; A Craig Chinault; Sau W Cheung; Paweł Stankiewicz
Journal:  Hum Genet       Date:  2006-06-22       Impact factor: 4.132

7.  Duplication of the Miller-Dieker Critical Region in a Patient with a Subtelomeric Unbalanced Translocation t(10;17)(p15.3;p13.3).

Authors:  R Ruiz Esparza-Garrido; A C Velázquez-Wong; M A Araujo-Solís; J C Huicochea-Montiel; M Á Velázquez-Flores; F Salamanca-Gómez; D J Arenas-Aranda
Journal:  Mol Syndromol       Date:  2012-07-10

Review 8.  Chromosome therapy. Correction of large chromosomal aberrations by inducing ring chromosomes in induced pluripotent stem cells (iPSCs).

Authors:  Taehyun Kim; Marina Bershteyn; Anthony Wynshaw-Boris
Journal:  Nucleus       Date:  2014 Sep-Oct       Impact factor: 4.197

9.  Lis1 is necessary for normal non-radial migration of inhibitory interneurons.

Authors:  Matthew F McManus; Ilya M Nasrallah; MacLean M Pancoast; Anthony Wynshaw-Boris; Jeffrey A Golden
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 10.  Cytoskeleton in action: lissencephaly, a neuronal migration disorder.

Authors:  Hyang Mi Moon; Anthony Wynshaw-Boris
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2013 Mar-Apr       Impact factor: 5.814

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.